Literature DB >> 7062211

Platelet dysfunction and coagulopathy in intraventricular hemorrhage in the premature infant.

E S Setzer, I B Webb, J W Wassenaar, J D Reeder, P S Mehta, D V Eitzman.   

Abstract

We investigated platelet count, bleeding time, platelet aggregation, prothrombin time, activated partial thromboplastin time, and fibrinogen level in 58 very low-birth-weight infants during the first postnatal day to determine the relationship between hemostatic disorders and intraventricular hemorrhage. Thirty-two of the 58 infants (55%) were found to have periventricular-intraventricular hemorrhage by computerized tomography or autopsy. Nine patients (16%) had subarachnoid hemorrhage only and 17 (29%) had no evidence of intracranial hemorrhage. Infants with IVH had a significantly lower mean platelet count than did infants with no SAH/IVH. However, only five patients with IVH had initial thrombocytopenia. The IVH group had a mean bleeding time which was significantly prolonged compared to that of the group without SAH/IVH. Similarly, patients with IVH had a mean platelet aggregation response which was significantly diminished in comparison to that of patients with no SAH/IVH. Infants with IVH had a significantly longer mean PT than did infants with no SAH/IVH. In addition, babies with IVH had a significantly longer mean APTT compared to that of babies without SAH/IVH. The groups did not differ significantly with respect to fibrinogen levels. Three infants with IVH had disseminated intravascular coagulation in the early neonatal period. These data suggest that disorders of platelet-capillary interaction and defects in the intrinsic and extrinsic coagulation pathways may play important roles in intraventricular hemorrhage in the premature infant.

Entities:  

Mesh:

Year:  1982        PMID: 7062211     DOI: 10.1016/s0022-3476(82)80766-x

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  17 in total

1.  Coagulation screening tests in high risk neonates: a prospective cohort study.

Authors:  B K Schmidt; P Vegh; M Andrew; M Johnston
Journal:  Arch Dis Child       Date:  1992-10       Impact factor: 3.791

2.  Abuse of fresh frozen plasma.

Authors:  R V Majer; P J Green; P Weir
Journal:  Br Med J (Clin Res Ed)       Date:  1987-09-12

Review 3.  One size will never fit all: the future of research in pediatric transfusion medicine.

Authors:  Cassandra D Josephson; Traci Heath Mondoro; Daniel R Ambruso; Rosa Sanchez; Steven R Sloan; Naomi L C Luban; John A Widness
Journal:  Pediatr Res       Date:  2014-08-13       Impact factor: 3.756

4.  Reduction in periventricular haemorrhage in preterm infants.

Authors:  W Szymonowicz; V Y Yu; A Walker; F Wilson
Journal:  Arch Dis Child       Date:  1986-07       Impact factor: 3.791

5.  Intracranial hemorrhage in newborn infants.

Authors:  S Shankaran
Journal:  Indian J Pediatr       Date:  1983 Jul-Aug       Impact factor: 1.967

6.  Cord blood gases, birth asphyxia, and intraventricular haemorrhage.

Authors:  D W Beverley; G Chance
Journal:  Arch Dis Child       Date:  1984-09       Impact factor: 3.791

7.  Prophylactic ethamsylate for periventricular haemorrhage.

Authors:  R W Cooke; M E Morgan
Journal:  Arch Dis Child       Date:  1984-01       Impact factor: 3.791

8.  Prevention of intraventricular haemorrhage by fresh frozen plasma.

Authors:  D W Beverley; T J Pitts-Tucker; P J Congdon; R J Arthur; G Tate
Journal:  Arch Dis Child       Date:  1985-08       Impact factor: 3.791

9.  Micromethod for bleeding time in the newborn.

Authors:  J M Rennie; T Gibson; R W Cooke
Journal:  Arch Dis Child       Date:  1985-01       Impact factor: 3.791

10.  Intraventricular haemorrhage and haemostasis defects.

Authors:  D W Beverley; G W Chance; M J Inwood; M Schaus; B O'Keefe
Journal:  Arch Dis Child       Date:  1984-05       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.